Form DEFA14A Olema Pharmaceuticals,
Tweet
Share
E-mail
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant |
þ |
|
|
Filed by a Party other than the Registrant |
☐ |
|
|
Check the appropriate box: |
|
|
|
☐ |
Preliminary Proxy Statement |
|
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
||
☐ |
Definitive Proxy Statement |
||
þ |
Definitive Additional Materials |
||
☐ |
Soliciting Material Pursuant to § 240.14a-12 |
||
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
þ |
No fee required. |
☐ |
Fee paid previously with preliminary materials. |
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HarbourView Equity Partners Announces Strategic Partnership With Hitmaking Powerhouse Wolf Cousins, the Acclaimed Songwriting Collective Founded by Shellback and Max Martin
- Natixis Investment Managers and Loomis Sayles Collaborate on Launch of Two Active Fixed Income ETFs
- Denny’s Unveils New Brand Evolution And Creative Campaign Drawing Inspiration From Classic Sitcoms
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
